Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.120929
Revised: April 9, 2026
Accepted: June 2, 2026
Published online: July 27, 2026
Processing time: 138 Days and 7.5 Hours
Percutaneous transhepatic biliary drainage (PTBD) remains an important salvage or urgent drainage option for biliary obstruction when endoscopic retrograde cholangiopancreatography fails or is not feasible. Evidence on bleeding and vascular complications after ultrasound-guided PTBD in low- and middle-income settings remains limited.
To determine the incidence and identify predictors of bleeding or vascular complications after ultrasound-guided PTBD.
We conducted a retrospective single-center cohort study of consecutive adults undergoing index PTBD for benign or malignant biliary obstruction at a tertiary hospital in Southern Vietnam from January 2021 to August 2023. All procedures were performed under real-time ultrasound guidance with color Doppler. Bleeding or vascular complications, defined using standardized criteria, were analyzed as the primary outcome, with clinically significant events reported separately. Associations were evaluated using a reduced Firth penalized logistic regression model including key procedural and disease-related variables, with internal validation by bootstrap resampling.
A total of 234 procedures were analyzed. Overall complications occurred in 33 patients (14.1%) and were predominantly minor. Bleeding or vascular complications occurred in 16 patients (6.8%), including 13 minor bleeding events (5.6%) and 3 clinically significant events (1.3%). No procedure-related mortality was observed within 14 days. Patients with bleeding or vascular complications had more frequent multiple needle passes and longer procedure times. In multivariable analysis, independent predictors included more than one needle pass [adjusted odds ratio (aOR): 7.91, 95% confidence interval (CI): 2.05-30.59], choledocholithiasis (aOR: 18.80, 95%CI: 4.79-73.73), longer procedure time per 10 minutes (aOR: 1.44, 95%CI: 1.05-1.96), and smaller target-duct diameter (aOR: 0.82 per 1 mm increase, 95%CI: 0.69-0.98). The model showed good discrimination (optimism-corrected area under the curve 0.85).
Ultrasound-guided percutaneous transhepatic biliary drainage demonstrates a low rate of clinically significant bleeding, with risk driven mainly by procedural difficulty and biliary pathology.
Core Tip: In this retrospective cohort study, ultrasound-guided percutaneous transhepatic biliary drainage performed without fluoroscopy demonstrated a low rate of clinically significant bleeding (1.3%). Bleeding or vascular complications were primarily as